Polygenic risk score (PRS) has recently emerged as a powerful tool for predicting the risk of complex traits by summarizing weighted single nucleotide polymorphisms (SNPs) associated with the trait(s). The data required for PRS construction, that is, SNPs and effect sizes, can be accessed from in-house association results or previously published association results as deposited in the PGS catalogue (https://www.pgscatalog.org/). PRS has been applicated in risk prediction and stratification for cancers, cardiometabolic diseases, and psychiatric disorders. 1,2 Despite the promising prospect of PRS in clinical application, the application of PRS in the general population is limited by ethnic inequality with respect to the training data. As of 2021, about 86% of genome-wide association study (GWAS) participants are European descendants, 3 mainly due to the scarcity of comprehensive genotyping data for non-European populations. Therefore, the prediction accuracy across non-European populations, i.e., the transferability of PRS, is often poor due to the difference in allele frequencies and linkage disequilibrium (LD) 4 patterns across populations. The insufficient transferability limits global clinical applicability and may increase disparities in PRS implementation among regions.Most recently, Qu et al. 5 addressed this limitation in the application of PRS for body mass index (BMI) in non-European populations. In this study, they developed a globally applicable trans-ethnic PRS for BMI from European ancestry GWAS by generating ethnic-specific LD reference panels and combining them into a BayesianThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.